Host cellular DNA transcription and translation machinery

The host cellular DNA transcription and translation machinery refers to the integrated system of enzymes and protein complexes, including RNA polymerases, the 80S ribosome, and various initiation and elongation factors, that execute the central dogma of molecular biology within a host cell [1.1.1, 1.1.5]. This machinery is responsible for the synthesis of mRNA from DNA templates and the subsequent assembly of amino acids into polypeptides [1.1.2]. In the context of oncology, these processes are frequently upregulated to sustain the high metabolic and proliferative demands of malignant cells, making components like eIF4A and the ribosome attractive therapeutic targets [1.1.1, 1.1.2]. Furthermore, many viruses lack their own translational apparatus and must hijack the host's machinery to produce viral proteins, which has led to the exploration of host-directed antivirals [1.1.5]. Drugs such as omacetaxine mepesuccinate (homoharringtonine) and dactinomycin exert their effects by directly inhibiting these fundamental processes [1.1.1, 1.1.4]. However, because this machinery is essential for the homeostasis of all eukaryotic cells, targeting it often results in significant systemic toxicity and a narrow therapeutic window [1.1.1, 1.1.3]. Consequently, modern drug development focuses on achieving selectivity for specific mRNA transcripts or disease-specific regulatory proteins within the machinery [1.1.1, 1.1.3].

Other names

Host cell machineryHost transcriptional and translational apparatusCellular protein synthesis machineryHost gene expression machinery

Inhibition of RNA polymerase activity, blockade of ribosome translocation, inhibition of translation initiation factors (e.g., eIF4A), or intercalation into DNA to prevent transcription.